10x Genomics, Inc. Class A Common Stock (TXG) Stock Price

TXGStock

$64.72+346.15%52W

Market Cap$8.43B

P/E—

PEG Ratio—

Div yield—

Beta2.06

TXG Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)214.76%

Price vs S&P 500 (4W)32.55%

VGM Score49.84

P/CF (Annual)55.88x

Book Value / Share (Quarterly)$6.34

P/TBV (Annual)2.81x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.57%

Cash Flow / Share (Quarterly)$0.93

Price vs S&P 500 (YTD)279.21%

Gross Margin (TTM)69.63%

Net Profit Margin (TTM)-12.18%

EPS (TTM)$-0.59

10-Day Avg Trading Volume3.13M

EPS Excl Extra (TTM)$-0.59

Revenue Growth (5Y)16.56%

EPS (Annual)$-0.35

ROI (Annual)-5.47%

Gross Margin (Annual)69.13%

Net Profit Margin (5Y Avg)-24.38%

Cash / Share (Quarterly)$4.24

Revenue Growth QoQ (YoY)-12.65%

ROA (Last FY)-4.18%

Revenue Growth TTM (YoY)-4.28%

EBITD / Share (TTM)$-0.38

ROE (5Y Avg)-18.67%

Operating Margin (TTM)-14.33%

Cash Flow / Share (Annual)$1.02

P/B Ratio9.21x

P/B Ratio (Quarterly)5.90x

Net Income / Employee (Annual)$-37,000

EV / Revenue (TTM)11.51x

Net Interest Coverage (TTM)-75.71x

ROA (TTM)-7.30%

EPS Incl Extra (Annual)$-0.35

Current Ratio (Annual)4.46x

Quick Ratio (Quarterly)5.09x

3-Month Avg Trading Volume3.13M

52-Week Price Return346.15%

EV / Free Cash Flow (Annual)54.57x

Revenue / Employee (TTM)$523,700

Tangible BV / Share (Quarterly)$5.87

P/S Ratio (Annual)11.83x

Asset Turnover (Annual)0.62x

52-Week High$65.47

Operating Margin (5Y Avg)-25.48%

EPS Excl Extra (Annual)$-0.35

CapEx CAGR (5Y)-31.16%

Tangible BV CAGR (5Y)0.48%

26-Week Price Return226.01%

Quick Ratio (Annual)3.95x

13-Week Price Return158.51%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)5.69x

Enterprise Value$7.10B

Revenue / Share Growth (5Y)11.78%

Asset Turnover (TTM)0.60x

Book Value / Share Growth (5Y)-1.75%

Revenue / Employee (Annual)$545,700

Inventory Turnover (Annual)2.85x

Pretax Margin (Annual)-6.21%

Cash / Share (Annual)$4.10

3-Month Return Std Dev80.89%

Gross Margin (5Y Avg)72.95%

Net Income / Employee (TTM)$-63,800

ROE (Last FY)-5.47%

Net Interest Coverage (Annual)-66.13x

EPS Basic Excl Extra (Annual)$-0.35

P/FCF (TTM)62.61x

Receivables Turnover (TTM)12.65x

EV / Free Cash Flow (TTM)58.47x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.59

Receivables Turnover (Annual)9.53x

ROI (TTM)-9.33%

P/S Ratio (TTM)12.32x

Pretax Margin (5Y Avg)-23.57%

Revenue / Share (Annual)$5.15

Tangible BV / Share (Annual)$5.75

Price vs S&P 500 (52W)327.84%

Year-to-Date Return291.17%

5-Day Price Return14.69%

EPS Normalized (Annual)$-0.35

ROA (5Y Avg)-14.47%

Net Profit Margin (Annual)-6.77%

Month-to-Date Return34.97%

Cash Flow / Share (TTM)$-1.64

EBITD / Share (Annual)$-0.20

Operating Margin (Annual)-9.49%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)59.83x

ROI (5Y Avg)-18.67%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.59

P/TBV (Quarterly)6.37x

P/B Ratio (Annual)2.59x

Inventory Turnover (TTM)3.08x

Pretax Margin (TTM)-12.14%

Book Value / Share (Annual)$6.24

Price vs S&P 500 (13W)155.72%

Beta2.06x

P/FCF (Annual)58.43x

Revenue / Share (TTM)$4.75

ROE (TTM)-9.33%

52-Week Low$11.16

vGradeF

gGradeD

mGradeA

vgmGradeC

TXG Earnings Surprise History

Q2 250.48est. -0.08

Q3 25-0.02est. -0.07

Q4 250.07est. -0.04

Q1 260.07est. -0.06

Q2 260.03est. -0.02

TXG Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.64

3.67

3.70

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$64.72
AAgilent Technologies Inc.	D	C	B	$154.77
WATWaters Corp	D	C	B	$414.44
ILMNIllumina Inc	D	D	A	$224.99
MTDMettler-Toledo International	D	C	B	$1402.25
RVTYRevvity, Inc.	C	D	B	$124.84
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$390.34
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
AVTRAvantor, Inc.	B	F	A	$14.42
BRKRBruker Corporation	D	D	B	$56.85
ALMRAlamar Biosciences, Inc. Common Stock	—	—	A	$33.02
CTKBCytek Biosciences, Inc. Common Stock	C	C	C	$4.58
PACBPacific Biosciences of California, Inc.	D	C	C	$1.52
MASS908 Devices Inc. Common Stock	C	C	A	$11.00
EYPTEyePoint, Inc. Common Stock	D	F	F	$5.00
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$23.25
LABStandard BioTools Inc. Common Stock	A	F	D	$0.65
QTRXQuanterix Corporation Common Stock	A	C	C	$2.79
SEERSeer, Inc. Class A Common Stock	C	D	C	$2.04
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.88
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.66
PRPOPrecipio, Inc. Common Stock	C	A	A	$30.85
HBIOHarvard Bioscience Inc	B	F	A	$7.58
ASTCAstrotech Corporation (DE) Common Stock	C	C	A	$7.10
BNGOBionano Genomics, Inc. Common Stock	A	C	C	$1.25
HLTHTema Healthcare AI ETF	—	F	D	$29.92
PRENWPrenetics Global Limited Warrant	—	—	D	$0.01

About 10x Genomics, Inc. Class A Common Stock

10x Genomics develops microfluidic-based instruments, consumables, and software for analyzing biological systems at high resolution and scale. The company's product portfolio includes the Chromium platform, Visium, and Xenium solutions, serving researchers and diagnostics customers globally across North America, Europe, Asia-Pacific, and China.